Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease

Area of Science:

• Nephrology
• Cardiovascular Science
• Molecular Biology

Background:

• Chronic kidney disease (CKD) is a significant global health issue.
• Mineralocorticoid receptor (MR) signaling is implicated in CKD progression.
• MR regulates fluid/electrolyte balance and modulates inflammation/fibrosis.

Purpose of the Study:

• To investigate the role of MR in nonepithelial cells in kidney and cardiovascular systems.
• To explore MR's contribution to inflammation and fibrosis in CKD.
• To identify potential therapeutic targets for MR signaling in nonepithelial cells.

Main Methods:

• Analysis of data from preclinical cell-specific MR knockout mouse models.
• Inclusion of in vitro studies examining MR function.
• Review of existing literature on MR signaling pathways.

Main Results:

• MR is expressed in various nonepithelial cells, including endothelial cells, vascular smooth muscle cells, podocytes, and fibroblasts.
• MR signaling in these nonepithelial cells influences kidney and cardiovascular inflammation and fibrosis.
• Preclinical models demonstrate the impact of cell-specific MR deletion.

Conclusions:

• Targeting MR in nonepithelial cells presents a potential therapeutic strategy for CKD.
• Understanding MR's role in diverse renal and vascular cell types is crucial for developing novel treatments.
• Further research into specific MR targets in nonepithelial cells is warranted.